392 related articles for article (PubMed ID: 19877301)
1. Zinc treatment for symptomatic Wilson disease: moving forward by looking back.
Schilsky M
Hepatology; 2009 Nov; 50(5):1341-3. PubMed ID: 19877301
[No Abstract] [Full Text] [Related]
2. Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients.
Linn FH; Houwen RH; van Hattum J; van der Kleij S; van Erpecum KJ
Hepatology; 2009 Nov; 50(5):1442-52. PubMed ID: 19731238
[TBL] [Abstract][Full Text] [Related]
3. Zinc Therapy for Wilson Disease in Children in French Pediatric Centers.
Santiago R; Gottrand F; Debray D; Bridoux L; Lachaux A; Morali A; Lapeyre D; Lamireau T
J Pediatr Gastroenterol Nutr; 2015 Dec; 61(6):613-8. PubMed ID: 26230903
[TBL] [Abstract][Full Text] [Related]
4. A copper for your thoughts.
Coates RA
J Insur Med; 2012; 43(2):112-5. PubMed ID: 22876415
[No Abstract] [Full Text] [Related]
5. Wilson disease--a practical approach to diagnosis, treatment and follow-up.
Medici V; Rossaro L; Sturniolo GC
Dig Liver Dis; 2007 Jul; 39(7):601-9. PubMed ID: 17382611
[TBL] [Abstract][Full Text] [Related]
6. Zinc toxicity: from "no, never" to "hardly ever".
Roberts EA
Gastroenterology; 2011 Apr; 140(4):1132-5. PubMed ID: 21349360
[No Abstract] [Full Text] [Related]
7. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of Wilson disease].
Smolarek C; Stremmel W
Z Gastroenterol; 1999 Apr; 37(4):293-300. PubMed ID: 10378366
[TBL] [Abstract][Full Text] [Related]
9. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice.
Hoogenraad TU
Brain Dev; 2006 Apr; 28(3):141-6. PubMed ID: 16466879
[TBL] [Abstract][Full Text] [Related]
10. [Wilson Disease].
Rev Prat; 2014 Apr; 64(4):564. PubMed ID: 24855798
[No Abstract] [Full Text] [Related]
11. Wilson's disease--treatment of psychiatric manifestations in pregnancy.
Rich AM; Lajoie TM
Psychosomatics; 2012; 53(2):175-7. PubMed ID: 22424165
[No Abstract] [Full Text] [Related]
12. The interactions of penicillamine with copper in vivo and the effect on hepatic metallothionein levels and copper/zinc distribution: the implications for Wilson's disease and arthritis therapy.
McQuaid A; Lamand M; Mason J
J Lab Clin Med; 1992 Jun; 119(6):744-50. PubMed ID: 1593220
[TBL] [Abstract][Full Text] [Related]
13. 'Face of the giant panda' sign in Wilson disease.
Thapa R; Ghosh A
Pediatr Radiol; 2008 Dec; 38(12):1355. PubMed ID: 18839167
[No Abstract] [Full Text] [Related]
14. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
[TBL] [Abstract][Full Text] [Related]
15. Effect of D-penicillamine on liver fibrosis and inflammation in Wilson disease.
Kazemi K; Geramizadeh B; Nikeghbalian S; Salahi H; Bahador A; Reza Nejatollahi SM; Dehghani SM; Dehghani M; Kakaei F; Malek-Hosseini SA
Exp Clin Transplant; 2008 Dec; 6(4):261-3. PubMed ID: 19338486
[TBL] [Abstract][Full Text] [Related]
16. [Hepatolenticular degeneration: biochemical and therapeutic considerations].
Clin Ter; 1976 Mar; 76(6):567-76. PubMed ID: 828082
[No Abstract] [Full Text] [Related]
17. Effects of long-term zinc treatment in Japanese patients with Wilson disease: efficacy, stability, and copper metabolism.
Shimizu N; Fujiwara J; Ohnishi S; Sato M; Kodama H; Kohsaka T; Inui A; Fujisawa T; Tamai H; Ida S; Itoh S; Ito M; Horiike N; Harada M; Yoshino M; Aoki T
Transl Res; 2010 Dec; 156(6):350-7. PubMed ID: 21078496
[TBL] [Abstract][Full Text] [Related]
18. [From gene to disease; Wilson disease: copper storage due to mutations in ATP7B].
Hoogenraad TU
Ned Tijdschr Geneeskd; 2003 Jul; 147(28):1386-7. PubMed ID: 12892020
[No Abstract] [Full Text] [Related]
19. Bone mineral density of children with Wilson disease: efficacy of penicillamine and zinc therapy.
Selimoglu MA; Ertekin V; Doneray H; Yildirim M
J Clin Gastroenterol; 2008 Feb; 42(2):194-8. PubMed ID: 18209591
[TBL] [Abstract][Full Text] [Related]
20. [Control of the therapeutic prevention of copper uptake in the liver in Wilson's disease following oral administration of 64Cu].
Günther K; Siegemund R; Lössner J; Kühn HJ
Radiobiol Radiother (Berl); 1988; 29(2):226-9. PubMed ID: 3399664
[No Abstract] [Full Text] [Related]
[Next] [New Search]